Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors???
- 1 December 1996
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 31 (6) , 444-469
- https://doi.org/10.2165/00003088-199631060-00004
Abstract
The recently introduced antidepressants, the selective serotonin reuptake inhibitors (SSRIs) [citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline], are known for their clinical efficacy,...Keywords
This publication has 98 references indexed in Scilit:
- Kinetics and Inhibition by Fluvoxamine of Phenacetin O‐Deethylation in V79 Cells Expressing Human CYP1A2Basic & Clinical Pharmacology & Toxicology, 1995
- Steady-State Kinetics of Fluoxetine and Amitriptyline in Patients Treated with a Combination of These Drugs as Compared with Those Treated with Amitriptyline AloneThe Journal of Clinical Pharmacology, 1995
- Pharmacokinetic Optimisation of Therapy with Newer AntidepressantsClinical Pharmacokinetics, 1994
- FluvoxamineDrugs, 1993
- SertralineDrugs, 1992
- High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetineJournal of Affective Disorders, 1992
- The pharmacological effect of citalopram resides in the (S)-(+)-enantiomerJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- ParoxetineDrugs, 1991
- Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patientsActa Psychiatrica Scandinavica, 1987
- The effects of citalopram (LU 10-171) on the serotonin (5-HT) uptake kinetics in platelets from endogenously depressed patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985